The idea of taking a drug to slow aging sounds like science fiction, but researchers are already testing medicines that target some of the biological processes linked with getting older.

Rapamycin, metformin, and senolytic drugs are among the best-known candidates. Still, there is an important catch: no medication has been proven to slow or reverse human aging, according to the FDA (1). 

Most research so far measures things like immune function, frailty, cellular senescence, or biological-age markers rather than human lifespan.

Key Takeaways:

• No drug is currently proven to extend human lifespan.

• Rapamycin has strong animal data, while human trials remain limited.

• Metformin has decades of medical use, but its longevity evidence in people is mixed.

• Senolytics can affect senescent cells in small human studies, but we do not yet know if this translates into longer or healthier lives.

What Are Anti-Aging Drugs?

Anti-aging drugs, sometimes called geroprotectors, are compounds being studied for their ability to influence biological processes involved in aging.

Rather than treating wrinkles or cosmetic signs of age, this research focuses on deeper cellular mechanisms such as:

• Nutrient sensing

• Cellular senescence

• Mitochondrial function

• Autophagy

• Chronic inflammation

• DNA and cellular repair

Many candidates are not new drugs. Researchers are repurposing medicines already used for diabetes, cancer, organ transplantation, and other conditions to see how they affect aging biology.

Which Anti-Aging Drugs Are Being Studied?

Rapamycin

Rapamycin gets a lot of attention because it inhibits mTOR, a nutrient-sensing pathway involved in cell growth, protein production, and autophagy.

Animal research has repeatedly linked mTOR inhibition with longer lifespan. Human evidence, though, tells a much smaller story.

A 48-week randomized trial tested 5 mg or 10 mg of rapamycin once weekly in healthy adults. Researchers found no significant change in visceral fat. Some improvements appeared in lean tissue mass and self-reported pain among women taking 10 mg, while several other outcomes showed no significant difference (2).

An earlier study tested everolimus, a drug related to rapamycin, in older adults. It improved their response to influenza vaccination by about 20%, suggesting that mTOR inhibition may influence age-related immune decline (3).

Interesting? Yes. Proof that rapamycin extends human life? Not yet.

Metformin

Metformin has become one of the most talked-about longevity drugs partly because millions of people already take it for type 2 diabetes.

Researchers are interested in its effects on glucose metabolism, insulin signaling, inflammation, and AMPK, another nutrient-sensing pathway.

A recent two-year randomized trial followed 145 older adults with glucose intolerance. Metformin improved one 95-item frailty index and produced small changes in biological age measured using some DNA methylation clocks. However, results differed depending on which frailty measure researchers used (4).

That distinction matters. A change in an aging biomarker does not automatically mean slower aging, better health, or longer life.

Senolytic Drugs

Senolytics take a different route. Instead of changing nutrient-sensing pathways, they aim to remove senescent cells.

These damaged cells have stopped dividing but remain metabolically active. As they accumulate, they can release inflammatory molecules that may affect nearby tissue.

One small trial gave nine people with diabetic kidney disease dasatinib plus quercetin for three days. Eleven days later, researchers found lower levels of several senescent-cell markers in fat and skin. One marker in fat tissue fell by about 35%, while another measure of cellular senescence fell by 62% (5).

Those numbers sound impressive, but this was only a nine-person pilot study. It showed that senolytic activity can occur in humans. It did not show that the treatment slows aging or extends lifespan.

How Could Anti-Aging Drugs Work?

Different drugs target different parts of aging biology.

Some of the main ideas include:

• Reducing excessive mTOR activity, which may encourage cellular maintenance and autophagy.

• Changing nutrient and energy sensing through pathways such as AMPK.

• Removing senescent cells that release inflammatory signals.

• Supporting cellular cleanup, repair, and stress responses.

Aging is not controlled by one switch, though. That is one reason researchers are unlikely to find a single pill that simply “turns aging off.”

Do Anti-Aging Drugs Really Make People Live Longer?

At this point, we do not know. Human lifespan studies are difficult for an obvious reason. Researchers cannot easily start a trial today and wait 40 years to see who lives longest.

Instead, anti-aging trials examine shorter-term outcomes such as:

• Frailty

• Walking speed

• Grip strength

• Immune response

• Senescent-cell markers

• Blood biomarkers

• Epigenetic aging clocks

• Development of age-related disease

These markers can teach researchers a lot, but they are not interchangeable with lifespan.

For example, improving an epigenetic clock score does not prove that someone added years to their life. Likewise, reducing senescent cells does not automatically mean fewer age-related diseases.

That gap between biological activity and proven longevity is one of the most important things to remember when reading anti-aging research.

Are Anti-Aging Drugs Safe?

Anti-aging drugs are biologically active medicines, not harmless longevity shortcuts.

Rapamycin affects immune signaling and may influence blood lipids, glucose regulation, wound healing, and infection risk.

Metformin has a much longer medical history, but it can cause digestive problems and may contribute to vitamin B12 deficiency during long-term use.

Dasatinib carries an even bigger warning sign. It is a prescription cancer medication with potentially serious adverse effects.

The doses, schedules, and risks used in longevity research may also differ from standard medical treatment. Taking prescription drugs without medical supervision based on animal longevity studies can create far more problems than it solves.

What Is the Future of Anti-Aging Medicine?

The future may look less like finding one miracle pill and more like matching specific therapies to specific aging processes.

One person may have poor metabolic health. Another may have greater immune decline or high levels of cellular senescence. Researchers are increasingly studying these pathways separately rather than treating aging as one simple condition.

Combinations may also become more important. Drugs, nutrition, exercise, sleep, and compounds targeting cellular metabolism could eventually form part of a broader healthy-aging strategy.

For now, that remains a research direction rather than a proven treatment plan.

Final Words

Anti-aging drugs are no longer just an idea from futuristic medicine. Researchers can already influence pathways linked with aging, remove some senescent cells, and change certain biomarkers in human trials.

The leap from that to living longer is much bigger.

Rapamycin has impressive animal longevity data, but limited human evidence. Metformin has decades of human use, yet research on aging remains mixed. Senolytics may remove certain senescent cells, although their clinical research is still at an early stage.

Supplements sit in a separate category from these prescription drugs. NMN, for example, is an NAD+ precursor rather than an anti-aging medication. 

One randomized study in older men found that taking 250 mg of NMN daily increased blood NAD+ levels, though researchers stressed that larger studies are still needed to understand its wider health effects (6).

At Omre, we take the same cautious approach. Our NMN + Resveratrol formula is designed around ingredients being studied for cellular health and healthy aging, without pretending that a supplement can stop aging or replace medical care.

FAQs

Is there an FDA-approved anti-aging drug?

No. The FDA states that no medication has been proven to slow or reverse the aging process.

Is rapamycin proven to slow aging?

Not in humans. Rapamycin has strong longevity evidence in animals, while human trials have mainly looked at safety, immune function, biomarkers, and healthspan-related outcomes.

Does metformin make you live longer?

Researchers do not yet know. Observational research and laboratory studies created interest in metformin, but clinical trials have not shown that it extends human lifespan.

What are senolytic drugs?

Senolytics are compounds designed to selectively remove senescent cells, which are damaged cells that stop dividing but remain active and may release inflammatory signals.

What is the most promising anti-aging drug?

There is no confirmed winner. Rapamycin, metformin, and senolytic drugs are among the most researched candidates, but none has been shown to extend human lifespan.

References

1. FDA guidance on anti-aging medication claims

2. 48-week PEARL trial of low-dose rapamycin in healthy adults

3. Human study of mTOR inhibition and immune function in older adults

4. Randomized trial of metformin, frailty, and biological age

5. Human pilot study of dasatinib plus quercetin and senescent cells

6. Randomized NMN trial in healthy older men